The Mayo Clinic School of Continuous Professional Development is hosting an interactive livestream CME event:
You must register at the website to participate.
In this interactive livestream event, course directors DeLisa Fairweather, Ph.D., Michael J. Joyner, M.D., R. Scott Wright, M.D., and leading experts from Mayo Clinic, Johns Hopkins, and the U.S. Food and Drug Administration will address a variety of topics related to COVID-19 Therapeutics in 2022 including:
This activity is intended for healthcare providers treating patients with COVID-19. It is designed for physicians, scientist researcher PhDs, physician assistants, nurse practitioners, nurses, pharmacists, residents, fellows and students.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Location: https://ce.mayo.edu/internal-medicine/content/covid-19-therapeutics-2022-advances-and-controversies-evidence-oversight-accessibility-and-2